"
Team:ATOMS-Turkiye/asoMain
From 2014.igem.org
Sayinorhan (Talk | contribs) |
|||
| Line 95: | Line 95: | ||
<ul> | <ul> | ||
<li class="one"> | <li class="one"> | ||
| - | <div><a href="https://2014.igem.org/Team:ATOMS-Turkiye/Modeling" class="tit">Modeling</a><a href="https://2014.igem.org/Team:ATOMS-Turkiye/Modeling" class="lnk"><span><strong>This year, we have carried out a mathematical modeling to understand how our promoter system would react against hypoxia to be able to treat heart problems. To learn more, click here</strong></span></a> | + | <div><a href="https://2014.igem.org/Team:ATOMS-Turkiye/Modeling" class="tit">Modeling</a><a href="https://2014.igem.org/Team:ATOMS-Turkiye/Modeling" class="lnk"><span><strong>This year, we have carried out a mathematical modeling to understand how our promoter system would react against hypoxia to be able to treat heart problems. To learn more, click here.</strong></span></a> |
| - | <img src="https://static.igem.org/mediawiki/2014/0/03/ATOMS-Modelling1.png" alt="This | + | <img src="https://static.igem.org/mediawiki/2014/0/03/ATOMS-Modelling1.png" alt="This year, we have carried out ..." width="210" height="220"><b>This year, we have carried out ....</b> |
</div> | </div> | ||
| Line 104: | Line 104: | ||
<div><a href="https://2014.igem.org/Team:ATOMS-Turkiye/BioBricks#main" class="tit">BioBricks</a><a href="https://2014.igem.org/Team:ATOMS-Turkiye/BioBricks#main" class="lnk"><span><strong>Our team proposes seven new eukaryotic cell parts to the Registry consisting of three promoters and four different enzymes with various capabilities. To get detailed information, proceed here.</strong></span></a> | <div><a href="https://2014.igem.org/Team:ATOMS-Turkiye/BioBricks#main" class="tit">BioBricks</a><a href="https://2014.igem.org/Team:ATOMS-Turkiye/BioBricks#main" class="lnk"><span><strong>Our team proposes seven new eukaryotic cell parts to the Registry consisting of three promoters and four different enzymes with various capabilities. To get detailed information, proceed here.</strong></span></a> | ||
| - | <img src="https://static.igem.org/mediawiki/2014/1/16/Atoms_turkiye_main_page_diagram.jpg" alt=" | + | <img src="https://static.igem.org/mediawiki/2014/1/16/Atoms_turkiye_main_page_diagram.jpg" alt="Our team proposes seven new eukaryotic cell parts ..." width="210" height="220"><b>Our team proposes seven new eukaryotic cell parts ...</b> |
</div> | </div> | ||
Revision as of 15:13, 17 October 2014
Project Abstract
Tissue hypoxia, or ischemia, is the condition that describes the poor conveyance of oxygen and other vital products to body tissues and organs which consequently results tissue death. Up to now, the number one cause of death worldwide is caused by ischemia and related conditions such as heart attack or stroke. It is needed to regard the big picture of the condition in order to solve the problem. In our project, our will is to build two different devices, which work synergistically, to fix these two distinct situations. We decided to use ‘’hypoxia inducible systems” and ‘’reactive oxygen species (ROS) sensitive gene fragments’’. These two receptors will hopefully regulate the release of clot dissolving factors and antioxidant peptides synthesized by our engineered vessel cells. We hope to bring encouraging results in vitro to pave the way of this promising system into the lifesaving remedy method.
-
BioBricksOur team proposes seven new eukaryotic cell parts to the Registry consisting of three promoters and four different enzymes with various capabilities. To get detailed information, proceed here.
Our team proposes seven new eukaryotic cell parts ...
This year, we have carried out ....
It was a long study session; but...
